Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Clinical trial NCT03587272 · RECRUITING
Trial details
- NCT number
- NCT03587272
- Sponsor
- Robert Nickel
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2030-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.